Back Li, P, Li, Z, Staton, E, et al (23 Oct 2024) 'GLP-1 receptor agonist and SGLT2 inhibitor prescribing in people With type 1 diabetes', JAMA Network , 332/19, 1667-69
That is the largest weight loss result ever recorded in a late-stage pharmaceutical trial for an obesity drug
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved these agents for glycaemic control in type 2 diabetes and, in specific formulations and doses (semaglutide as Wegovy and liraglutide as Saxenda), for weight management in adults with obesity or overweight with weight-related comorbidities
It is legit
Resin: This is the solid support material that provides a base for building chains of amino acids during SPPS
Despite this concentration, the competitive landscape is evolving rapidly